Study of the clinical and preclinical stages of genetic forms of frontotemporal lobar degeneration (FTLD) and research of biomarkers of progression of the disease
Les dégénérescences lobaires fronto-temporale (DLFT) sont des démences neurodégénératives rares. 30-50% des DLFT a une cause génétique, la plupart sont des mutations des gènes C9orf72 et progranuline (GRN). L'objectif de la thèse a été d'élargir le spectre mutationnel et phénotypique des m...
Main Author: | Caroppo, Paola |
---|---|
Other Authors: | Paris 6 |
Language: | en |
Published: |
2016
|
Subjects: | |
Online Access: | http://www.theses.fr/2016PA066116 |
Similar Items
-
Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration
by: Qin Chen, et al.
Published: (2020-02-01) -
Development of TDP-43 granule inhibitors as potential amyotrophic lateral sclerosis and frontotemporal lobar degeneration therapies
by: Ebata, Atsushi
Published: (2016) -
Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration
by: Ione O. C. Woollacott, et al.
Published: (2020-08-01) -
Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease
by: Anne Rovelet-Lecrux, et al.
Published: (2008-07-01) -
Dégénérescences lobaires frontotemporales : vers une nouvelle classification, vers de nouveaux marqueurs
by: Papegaey, Anthony
Published: (2016)